{"id":2797,"date":"2022-07-19T10:33:52","date_gmt":"2022-07-19T10:33:52","guid":{"rendered":"https:\/\/mmevost.wpenginepowered.com\/success-stories\/genetika-rxmine-depresion-eic-financiacion-europea\/"},"modified":"2025-11-28T11:02:57","modified_gmt":"2025-11-28T11:02:57","slug":"genetika-rxmine-depresion-eic-financiacion-europea","status":"publish","type":"success-stories","link":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/","title":{"rendered":"Genetika+ \u2013 RxMine"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>La depresi\u00f3n cl\u00ednica afecta a m\u00e1s de 300 millones de personas en todo el mundo y crece un 37% cada d\u00e9cada. Los pacientes no suelen recibir una atenci\u00f3n adecuada debido a su car\u00e1cter heterog\u00e9neo, que afecta a cada individuo de forma diferente y conlleva una variedad de respuestas&#8230; <\/p>\n","protected":false},"featured_media":2404,"template":"","meta":{"_acf_changed":false},"flags":[96],"program":[46],"sector":[36],"class_list":["post-2797","success-stories","type-success-stories","status-publish","has-post-thumbnail","hentry","flags-il","program-instrumento-pyme-eic-accelerator","sector-salud"],"acf":{"layouts_cases":[{"acf_fc_layout":"content","content":{"sections_settings":{"section_id":"","section_background":false,"section_padding":"base"},"content":"La depresi\u00f3n cl\u00ednica afecta a m\u00e1s de 300 millones de personas en todo el mundo y crece un 37% cada d\u00e9cada. Los pacientes no suelen recibir una atenci\u00f3n adecuada debido a su car\u00e1cter heterog\u00e9neo, que afecta a cada individuo de forma diferente y conlleva una variedad de respuestas\u00a0 distintas a los tratamientos. Esta situaci\u00f3n provoca problemas sociales y un aumento de costes econ\u00f3micos, alcanzando los 170.000 millones de euros anuales en la UE.\r\n\r\nPara adaptar cada tratamiento y garantizar la mejor calidad de vida de los pacientes, <a href=\"https:\/\/www.genetikaplus.com\/\" target=\"_blank\" rel=\"noopener\">Genetika+<\/a> ha creado RxMine, una soluci\u00f3n de medicina personalizada para la depresi\u00f3n. Mediante un sencillo an\u00e1lisis de sangre y algoritmos de <i>machine learning<\/i>, RxMine puede analizar decenas de escenarios y combinaciones <i>in vitro<\/i> de f\u00e1rmacos para estudiar la opci\u00f3n m\u00e1s adecuada a la capacidad de respuesta de cada paciente.\r\n\r\nCon esta b\u00fasqueda del tratamiento adecuado, Genetika+ representa la mejora de la situaci\u00f3n de la depresi\u00f3n en todo el mundo: reduciendo el sufrimiento de los pacientes y mejorando su d\u00eda a d\u00eda."}},{"acf_fc_layout":"media","media":{"sections_settings":{"section_id":"","section_background":false,"section_padding":"base"},"intro":"","section_type":"image","image":2402,"video_type":"mp4","upload_video":"","video_id":"","video_placeholder":"","video_title":"","button":null}},{"acf_fc_layout":"media","media":{"sections_settings":{"section_id":"","section_background":false,"section_padding":"base"},"intro":"","section_type":"video","image":"","video_type":"youtube","upload_video":"","video_id":"ESBRiDk3hZY","video_placeholder":null,"video_title":"","button":null}}],"layouts":null},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Genetika+ \u2013 RxMine - evolution-europe<\/title>\n<meta name=\"description\" content=\"La depresi\u00f3n cl\u00ednica afecta a m\u00e1s de 300 millones de personas en todo el mundo y crece un 37% cada d\u00e9cada. Los pacientes no suelen recibir una atenci\u00f3n adecuada debido a su car\u00e1cter heterog\u00e9neo, que afecta a cada individuo de forma diferente y conlleva una variedad de respuestas...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genetika+ \u2013 RxMine\" \/>\n<meta property=\"og:description\" content=\"La depresi\u00f3n cl\u00ednica afecta a m\u00e1s de 300 millones de personas en todo el mundo y crece un 37% cada d\u00e9cada. Los pacientes no suelen recibir una atenci\u00f3n adecuada debido a su car\u00e1cter heterog\u00e9neo, que afecta a cada individuo de forma diferente y conlleva una variedad de respuestas...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/\" \/>\n<meta property=\"og:site_name\" content=\"evolution-europe\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-28T11:02:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2025\/10\/alt_genetika_plus_depression_eic_funding_european.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/genetika-rxmine-depresion-eic-financiacion-europea\\\/\",\"url\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/genetika-rxmine-depresion-eic-financiacion-europea\\\/\",\"name\":\"Genetika+ \u2013 RxMine - evolution-europe\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/genetika-rxmine-depresion-eic-financiacion-europea\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/genetika-rxmine-depresion-eic-financiacion-europea\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/evolutioneurope.eu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/alt_genetika_plus_depression_eic_funding_european.jpg\",\"datePublished\":\"2022-07-19T10:33:52+00:00\",\"dateModified\":\"2025-11-28T11:02:57+00:00\",\"description\":\"La depresi\u00f3n cl\u00ednica afecta a m\u00e1s de 300 millones de personas en todo el mundo y crece un 37% cada d\u00e9cada. Los pacientes no suelen recibir una atenci\u00f3n adecuada debido a su car\u00e1cter heterog\u00e9neo, que afecta a cada individuo de forma diferente y conlleva una variedad de respuestas...\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/genetika-rxmine-depresion-eic-financiacion-europea\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/genetika-rxmine-depresion-eic-financiacion-europea\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/genetika-rxmine-depresion-eic-financiacion-europea\\\/#primaryimage\",\"url\":\"https:\\\/\\\/evolutioneurope.eu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/alt_genetika_plus_depression_eic_funding_european.jpg\",\"contentUrl\":\"https:\\\/\\\/evolutioneurope.eu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/alt_genetika_plus_depression_eic_funding_european.jpg\",\"width\":800,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/genetika-rxmine-depresion-eic-financiacion-europea\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Success stories\",\"item\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Genetika+ \u2013 RxMine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/\",\"name\":\"evolution-europe\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#organization\",\"name\":\"Evolution Europe\",\"url\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/evolutioneurope.eu\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/social-share-image-2000x1600-1.jpg\",\"contentUrl\":\"https:\\\/\\\/evolutioneurope.eu\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/social-share-image-2000x1600-1.jpg\",\"width\":2000,\"height\":1600,\"caption\":\"Evolution Europe\"},\"image\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Genetika+ \u2013 RxMine - evolution-europe","description":"La depresi\u00f3n cl\u00ednica afecta a m\u00e1s de 300 millones de personas en todo el mundo y crece un 37% cada d\u00e9cada. Los pacientes no suelen recibir una atenci\u00f3n adecuada debido a su car\u00e1cter heterog\u00e9neo, que afecta a cada individuo de forma diferente y conlleva una variedad de respuestas...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/","og_locale":"es_ES","og_type":"article","og_title":"Genetika+ \u2013 RxMine","og_description":"La depresi\u00f3n cl\u00ednica afecta a m\u00e1s de 300 millones de personas en todo el mundo y crece un 37% cada d\u00e9cada. Los pacientes no suelen recibir una atenci\u00f3n adecuada debido a su car\u00e1cter heterog\u00e9neo, que afecta a cada individuo de forma diferente y conlleva una variedad de respuestas...","og_url":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/","og_site_name":"evolution-europe","article_modified_time":"2025-11-28T11:02:57+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2025\/10\/alt_genetika_plus_depression_eic_funding_european.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/","url":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/","name":"Genetika+ \u2013 RxMine - evolution-europe","isPartOf":{"@id":"https:\/\/evolutioneurope.eu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/#primaryimage"},"image":{"@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/#primaryimage"},"thumbnailUrl":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2025\/10\/alt_genetika_plus_depression_eic_funding_european.jpg","datePublished":"2022-07-19T10:33:52+00:00","dateModified":"2025-11-28T11:02:57+00:00","description":"La depresi\u00f3n cl\u00ednica afecta a m\u00e1s de 300 millones de personas en todo el mundo y crece un 37% cada d\u00e9cada. Los pacientes no suelen recibir una atenci\u00f3n adecuada debido a su car\u00e1cter heterog\u00e9neo, que afecta a cada individuo de forma diferente y conlleva una variedad de respuestas...","breadcrumb":{"@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/#primaryimage","url":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2025\/10\/alt_genetika_plus_depression_eic_funding_european.jpg","contentUrl":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2025\/10\/alt_genetika_plus_depression_eic_funding_european.jpg","width":800,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/genetika-rxmine-depresion-eic-financiacion-europea\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/evolutioneurope.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Success stories","item":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/"},{"@type":"ListItem","position":3,"name":"Genetika+ \u2013 RxMine"}]},{"@type":"WebSite","@id":"https:\/\/evolutioneurope.eu\/es\/#website","url":"https:\/\/evolutioneurope.eu\/es\/","name":"evolution-europe","description":"","publisher":{"@id":"https:\/\/evolutioneurope.eu\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/evolutioneurope.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/evolutioneurope.eu\/es\/#organization","name":"Evolution Europe","url":"https:\/\/evolutioneurope.eu\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/evolutioneurope.eu\/es\/#\/schema\/logo\/image\/","url":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2026\/04\/social-share-image-2000x1600-1.jpg","contentUrl":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2026\/04\/social-share-image-2000x1600-1.jpg","width":2000,"height":1600,"caption":"Evolution Europe"},"image":{"@id":"https:\/\/evolutioneurope.eu\/es\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/success-stories\/2797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/success-stories"}],"about":[{"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/types\/success-stories"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/media\/2404"}],"wp:attachment":[{"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/media?parent=2797"}],"wp:term":[{"taxonomy":"flags","embeddable":true,"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/flags?post=2797"},{"taxonomy":"program","embeddable":true,"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/program?post=2797"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/sector?post=2797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}